Condition
Cesarean Scar Pregnancy
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed2
Unknown2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07166627RecruitingPrimary
Comparison Between Surgical Excision and Ultrasound Guided Evacuation in Management of Cesarean Section Scar Pregnancy.
NCT05839574Not ApplicableCompletedPrimary
Letrozole add-on in the Treatment of Cesarean Scar Pregnancy
NCT04955028CompletedPrimary
MRI in Predicting Intraoperative Massive Hemorrhage for Cesarean Scar Pregnancy
NCT04379219Phase 4UnknownPrimary
Surgery Alone Versus Methotrexate Before Surgery in Cesarean Scar Pregnancy
NCT03218059Not ApplicableUnknownPrimary
Outcome After MTX & Transvaginal Surgery or UAE & Uterine Curettage in Patients With Cesarean Scar Pregnancy
Showing all 5 trials